Filing Details
- Accession Number:
- 0001209191-21-033362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-17 21:57:01
- Reporting Period:
- 2021-05-15
- Accepted Time:
- 2021-05-17 21:57:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776662 | A. Badrul Chowdhury | 6836 Bee Cave Road Building Iii, Suite 200 Austin TX 78746 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-15 | 200,000 | $0.00 | 200,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-17 | 50,000 | $1.56 | 150,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-05-15 | 200,000 | $0.00 | 200,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2020 in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 15, 2021.
- The price is a weighted average sale price. The sale prices ranged from $1.50 to $1.61. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The restricted stock units vested in full on May 15, 2021.
Billionaire Hedge Funds
